{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T10:34:04Z","timestamp":1760783644930},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.neuropharm.2013.01.022","type":"journal-article","created":{"date-parts":[[2013,2,13]],"date-time":"2013-02-13T22:46:35Z","timestamp":1360795595000},"page":"19-26","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Pharmacological modulation of geranylgeranyltransferase and farnesyltransferase attenuates opioid withdrawal in\u00a0vivo and in\u00a0vitro"],"prefix":"10.1016","volume":"71","author":[{"given":"Ashish K.","family":"Rehni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thakur Gurjeet","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"35","key":"10.1016\/j.neuropharm.2013.01.022_bib1","doi-asserted-by":"crossref","first-page":"21309","DOI":"10.1074\/jbc.271.35.21309","article-title":"Chronic opioid treatment induces adenylyl cyclase v superactivation involvement of G\u03b2\u03b3","volume":"271","author":"Avidor-Reiss","year":"1996","journal-title":"J.\u00a0Biol. Chem."},{"issue":"1","key":"10.1016\/j.neuropharm.2013.01.022_bib2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0014-2999(87)90176-2","article-title":"Effects of peripheral and central administration of calcium channel blockers in the naloxone-precipitated abstinence syndrome in morphine-dependent rats","volume":"137","author":"Baeyens","year":"1987","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2013.01.022_bib3","doi-asserted-by":"crossref","first-page":"78","DOI":"10.2174\/1874091X00903010078","article-title":"Molecules acting on CB1 receptor and their effects on morphine withdrawal in\u00a0vitro","volume":"3","author":"Capasso","year":"2009","journal-title":"Open Biochem. J."},{"key":"10.1016\/j.neuropharm.2013.01.022_bib4","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/sj.bjp.0700995","article-title":"Differential influence of D1 and D2 dopamine receptors on acute opiate withdrawal in guinea-pig isolated ileum","volume":"120","author":"Capasso","year":"1997","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2013.01.022_bib5","series-title":"Statistical Inference","author":"Cassella","year":"2002"},{"issue":"24","key":"10.1016\/j.neuropharm.2013.01.022_bib6","doi-asserted-by":"crossref","first-page":"11368","DOI":"10.1073\/pnas.88.24.11368","article-title":"Cloning and expression of a cDNA encoding the alpha subunit of rat p21ras protein farnesyltransferase","volume":"88","author":"Chen","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2013.01.022_bib7","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s002130050026","article-title":"Up-regulation of neuronal NO synthase immunoreactivity in opiate dependence and withdrawal","volume":"148","author":"Cuellar","year":"2000","journal-title":"Psychopharmacol. (Berl)"},{"key":"10.1016\/j.neuropharm.2013.01.022_bib8","first-page":"74","article-title":"A\u00a0method for determining loss of pain sensation","volume":"72","author":"D'Amour","year":"1941","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"issue":"17","key":"10.1016\/j.neuropharm.2013.01.022_bib9","doi-asserted-by":"crossref","first-page":"7384","DOI":"10.1021\/ja211305j","article-title":"Psoromic acid is a selective and covalent Rab-prenylation inhibitor targeting autoinhibited RabGGTase","volume":"134","author":"Deraeve","year":"2012","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.neuropharm.2013.01.022_bib10","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1037\/0735-7044.103.4.842","article-title":"Procedures that produce context-specific tolerance to morphine in rats also produce context-specific withdrawal","volume":"103","author":"Falls","year":"1989","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2013.01.022_bib11","doi-asserted-by":"crossref","first-page":"38478","DOI":"10.1074\/jbc.M505644200","article-title":"A\u00a0role for the distal carboxyl tails in generating the novel pharmacology and G protein activation profile of mu and delta opioid receptor hetero-oligomers","volume":"280","author":"Fan","year":"2005","journal-title":"J.\u00a0Biol. Chem."},{"issue":"2","key":"10.1016\/j.neuropharm.2013.01.022_bib12","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/(SICI)1097-0215(19991008)83:2<235::AID-IJC15>3.0.CO;2-B","article-title":"Selective GRB2 SH2 inhibitors as anti-Ras therapy","volume":"83","author":"Gay","year":"1999","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.neuropharm.2013.01.022_bib13","doi-asserted-by":"crossref","first-page":"26128","DOI":"10.1074\/jbc.M000345200","article-title":"Oligomerization of mu- and delta-opioid receptors. generation of novel functional properties","volume":"275","author":"George","year":"2000","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2013.01.022_bib14","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1523\/JNEUROSCI.23-08-03106.2003","article-title":"Involvement of the lateral hypothalamic peptide orexin in morphine dependence and withdrawal","volume":"23","author":"Georgescu","year":"2003","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2013.01.022_bib15","doi-asserted-by":"crossref","first-page":"15575","DOI":"10.1016\/S0021-9258(18)98441-3","article-title":"Nonfarnesylated tetrapeptide inhibitors of protein farnesyltransferase","volume":"266","author":"Goldstein","year":"1991","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2013.01.022_bib16","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/npp.2010.197","article-title":"The role of TNFa in the periaqueductal gray during naloxone-precipitated morphine withdrawal in rats","volume":"36","author":"Hao","year":"2011","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.neuropharm.2013.01.022_bib17","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1007\/s00216-010-4088-7","article-title":"A\u00a0rapid and sensitive assay for determining human brain levels of farnesyl-(FPP) and geranylgeranylpyrophosphate (GGPP) and transferase activities using UHPLC-MS\/MS","volume":"398","author":"Hooff","year":"2010","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.neuropharm.2013.01.022_bib18","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1046\/j.1471-4159.2000.0740199.x","article-title":"Role of corticotropin-releasing factor receptor-1 in opiate withdrawal","volume":"74","author":"Iredale","year":"2000","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2013.01.022_bib19","doi-asserted-by":"crossref","first-page":"13495","DOI":"10.1016\/S0021-9258(18)92724-9","article-title":"In\u00a0vitro identification of a soluble protein:geranylgeranyl transferase from rat tissues","volume":"266","author":"Joly","year":"1991","journal-title":"J.\u00a0Biol. Chem."},{"issue":"6","key":"10.1016\/j.neuropharm.2013.01.022_bib20","doi-asserted-by":"crossref","first-page":"3940","DOI":"10.1016\/S0021-9258(19)50616-0","article-title":"Rab GTP-binding proteins with three different carboxyl-terminal cysteine motifs are modified in\u00a0vivo by 20-Carbon isoprenoids","volume":"267","author":"Kinsella","year":"1992","journal-title":"J.\u00a0Biol. Chem."},{"issue":"7","key":"10.1016\/j.neuropharm.2013.01.022_bib21","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nrd2221","article-title":"Post-translational modifications and regulation of the RAS superfamily of GTPases as anticancer targets","volume":"6","author":"Konstantinopoulos","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuropharm.2013.01.022_bib22","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1001\/archinte.164.3.277","article-title":"Treating opioid dependence growing implications for primary care","volume":"164","author":"Krantz","year":"2004","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.neuropharm.2013.01.022_bib23","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1194\/jlr.R600002-JLR200","article-title":"Structural biology of protein farnesyltransferase and geranylgeranyltransferase type I","volume":"47","author":"Lane","year":"2006","journal-title":"J.\u00a0Lipid Res."},{"issue":"45","key":"10.1016\/j.neuropharm.2013.01.022_bib24","doi-asserted-by":"crossref","first-page":"26802","DOI":"10.1074\/jbc.270.45.26802","article-title":"Ras CAAX peptidomimetic FTI-277 selectively blocks oncogenic Ras signaling by inducing cytoplasmic accumulation of inactive Ras\u2013Raf complexes","volume":"270","author":"Lerner","year":"1995","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2013.01.022_bib25","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1194\/jlr.R500017-JLR200","article-title":"Geranylgeranylation of Rab GTPases","volume":"47","author":"Leung","year":"2006","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.neuropharm.2013.01.022_bib26","series-title":"Pain and Headache, Neurotransmitters and Pain Control","first-page":"129","article-title":"Opioids and pain regulation","author":"Lewis","year":"1987"},{"key":"10.1016\/j.neuropharm.2013.01.022_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-0173(01)00057-1","article-title":"Protein kinases modulate the cellular adaptations associated with opioid tolerance and dependence","volume":"38","author":"Liu","year":"2001","journal-title":"Brain Res. Brain Res. Rev."},{"key":"10.1016\/j.neuropharm.2013.01.022_bib28","first-page":"285","article-title":"Effects of sinomenine on NO\/nNOS system in cerebellum and spinal cord of morphine-dependent and withdrawal mice","volume":"59","author":"Liu","year":"2007","journal-title":"Sheng Li Xue Bao"},{"key":"10.1016\/j.neuropharm.2013.01.022_bib29","first-page":"557","article-title":"Modulation of Ca21\/Calmodulin-dependent protein kinase II activity by acute and chronic morphine administration in rat hippocampus: differential regulation of \u03b1 and \u03b2 isoforms","volume":"55","author":"Lou","year":"1999","journal-title":"Mol. Pharmacol."},{"issue":"1","key":"10.1016\/j.neuropharm.2013.01.022_bib30","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.neulet.2012.06.039","article-title":"Thioredoxin-1 expression regulated by morphine in SH-SY5Y cells","volume":"523","author":"Luo","year":"2012","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2013.01.022_bib31","first-page":"634","article-title":"Evidence against a role of brain 5 hydroxytryptamine in the development of physical dependence upon morphine in mice","volume":"173","author":"Marshall","year":"1971","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"issue":"3","key":"10.1016\/j.neuropharm.2013.01.022_bib32","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0028-3908(01)00076-4","article-title":"Control of the efficiency of agonist-induced information transfer and stability of the ternary complex containing the delta opioid receptor and the alpha subunit of G(i1) by mutation of a receptor\/G protein contact interface","volume":"41","author":"Moon","year":"2001","journal-title":"Neuropharmacology"},{"issue":"8","key":"10.1016\/j.neuropharm.2013.01.022_bib33","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1097\/FBP.0b013e3282f18da6","article-title":"Comparison of nitric oxide synthase inhibitors, phospholipase A2 inhibitor and free radical scavengers as attenuators of opioid withdrawal syndrome","volume":"18","author":"Mori","year":"2007","journal-title":"Behav. Pharmacol."},{"issue":"6","key":"10.1016\/j.neuropharm.2013.01.022_bib34","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1096\/fj.05-5067fje","article-title":"Atorvastatin desensitizes beta-adrenergic signaling in cardiac myocytes via reduced isoprenylation of G-protein gamma-subunits","volume":"20","author":"M\u00fchlh\u00e4user","year":"2006","journal-title":"FASEB J."},{"issue":"2","key":"10.1016\/j.neuropharm.2013.01.022_bib35","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.cellsig.2009.09.017","article-title":"Prenylation deficient G protein gamma subunits disrupt GPCR signalling in the zebrafish","volume":"22","author":"Mulligan","year":"2010","journal-title":"Cell. Signal."},{"key":"10.1016\/j.neuropharm.2013.01.022_bib36","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.tips.2004.02.005","article-title":"Historical review: molecular and cellular mechanisms of opiate and cocaine addiction","volume":"25","author":"Nestler","year":"2004","journal-title":"Trends Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.neuropharm.2013.01.022_bib37","doi-asserted-by":"crossref","first-page":"129","DOI":"10.4161\/auto.5.1.7329","article-title":"Farnesyltransferase inhibitors-induced autophagy: alternative mechanisms?","volume":"5","author":"Pan","year":"2009","journal-title":"Autophagy"},{"issue":"3","key":"10.1016\/j.neuropharm.2013.01.022_bib38","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0968-0896(97)10040-2","article-title":"Selective inhibition of type-I geranylgeranyltransferase in\u00a0vitro and in whole cells by CAAL peptidomimetics","volume":"6","author":"Qian","year":"1998","journal-title":"Bioorg. Med. Chem."},{"issue":"2","key":"10.1016\/j.neuropharm.2013.01.022_bib39","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/FBP.0b013e328343d7a0","article-title":"Modulation of src-kinase attenuates naloxone-precipitated opioid withdrawal syndrome in mice","volume":"22","author":"Rehni","year":"2011","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuropharm.2013.01.022_bib40","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00213-011-2489-8","article-title":"Ammonium pyrrolidine dithiocarbamate and RS 102895 attenuates opioid withdrawal in\u00a0vivo and in\u00a0vitro","volume":"220","author":"Rehni","year":"2012","journal-title":"Psychopharmacol. (Berl)"},{"issue":"3","key":"10.1016\/j.neuropharm.2013.01.022_bib41","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/FBP.0b013e32835398ec","article-title":"Potential involvement of tyrosine phosphatase and calpain-related pathways in opioid withdrawal syndrome in mice","volume":"23","author":"Rehni","year":"2012","journal-title":"Behav. Pharmacol."},{"issue":"3","key":"10.1016\/j.neuropharm.2013.01.022_bib42","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/FBP.0b013e3282febcd9","article-title":"Nuclear factor-kappa-B inhibitor modulates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome","volume":"19","author":"Rehni","year":"2008","journal-title":"Behav. Pharmacol."},{"issue":"1\u20133","key":"10.1016\/j.neuropharm.2013.01.022_bib43","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ejphar.2008.09.025","article-title":"Pharmacological modulation of leukotriene D(4) attenuates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome","volume":"598","author":"Rehni","year":"2008","journal-title":"Eur. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.neuropharm.2013.01.022_bib44","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s00210-012-0739-x","article-title":"Modulation of histone deacetylase attenuates naloxone-precipitated opioid withdrawal syndrome","volume":"385","author":"Rehni","year":"2012","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.neuropharm.2013.01.022_bib45","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0092-8674(90)90242-7","article-title":"Inhibition of purified p21ras farnesyl:protein transferase by Cys-AAX tetrapeptides","volume":"62","author":"Reiss","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2013.01.022_bib46","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1038\/sj.onc.1210422","article-title":"Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer","volume":"26","author":"Roberts","year":"2007","journal-title":"Oncogene"},{"issue":"11","key":"10.1016\/j.neuropharm.2013.01.022_bib47","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1111\/j.1460-9568.2007.05935.x","article-title":"Farnesyl transferase inhibitors induce neuroprotection by inhibiting Ha-Ras signalling pathway","volume":"26","author":"Ruocco","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2013.01.022_bib48","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/sj.bjp.0706661","article-title":"Differential activation of G-proteins by \u03bc-opioid receptor agonists","volume":"147","author":"Saidak","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2013.01.022_bib49","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1073\/pnas.74.8.3365","article-title":"Opiate-dependent modulation of adenylate cyclase","volume":"74","author":"Sharma","year":"1977","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.neuropharm.2013.01.022_bib50","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1523\/JNEUROSCI.19-06-02347.1999","article-title":"Presynaptic inhibition of GABAB-mediated synaptic potentials in the ventral tegmental area during morphine withdrawal","volume":"19","author":"Shoji","year":"1999","journal-title":"J.\u00a0Neurosci."},{"issue":"3","key":"10.1016\/j.neuropharm.2013.01.022_bib51","first-page":"192","article-title":"Roles of the Raf\/MEK\/ERK and PI3K\/PTEN\/Akt\/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging","volume":"3","author":"Steelman","year":"2011","journal-title":"Aging (Albany NY.)"},{"issue":"2","key":"10.1016\/j.neuropharm.2013.01.022_bib52","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00210-003-0773-9","article-title":"Interactive role of adenosine and dopamine in the opiate withdrawal syndrome","volume":"368","author":"Stella","year":"2003","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"issue":"1","key":"10.1016\/j.neuropharm.2013.01.022_bib53","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s12035-012-8249-x","article-title":"Prenylation of Rho G-proteins: a novel mechanism regulating gene expression and protein stability in human trabecular meshwork cells","volume":"46","author":"Stubbs","year":"2012","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2013.01.022_bib54","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/0024-3205(89)90148-3","article-title":"Statistical analysis of drug-drug and site-site interactions with isobolograms","volume":"45","author":"Tallarida","year":"1989","journal-title":"Life Sci."},{"issue":"44","key":"10.1016\/j.neuropharm.2013.01.022_bib55","doi-asserted-by":"crossref","first-page":"27225","DOI":"10.1074\/jbc.271.44.27225","article-title":"Signaling from the small GTP-binding proteins Rac1 and Cdc42 to the c-Jun N-terminal kinase\/stress-activated protein kinase pathway. A role for mixed lineage kinase 3\/protein-tyrosine kinase 1, a novel member of the mixed lineage kinase family","volume":"271","author":"Teramoto","year":"1996","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2013.01.022_bib56","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/jnr.490320412","article-title":"Sub-chronic exposure to opiates in the rat: effects on brain levels of substance P and calcitonin gene related peptide during dependence and withdrawal","volume":"32","author":"Tiong","year":"1992","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2013.01.022_bib57","doi-asserted-by":"crossref","first-page":"4328","DOI":"10.1523\/JNEUROSCI.22-11-04328.2002","article-title":"G-protein-gated potassium channels containing Kir3.2 and Kir3.3 subunits mediate the acute inhibitory effects of opioids on locus ceruleus neurons","volume":"22","author":"Torrecilla","year":"2002","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2013.01.022_bib58","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/sj.bjp.0704681","article-title":"The role of spinal neuropeptides and prostaglandins in opioid physical dependence","volume":"136","author":"Trang","year":"2002","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2013.01.022_bib59","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1126\/science.1824728","article-title":"Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801","volume":"251","author":"Trujillo","year":"1991","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.neuropharm.2013.01.022_bib60","first-page":"1","article-title":"Simultaneous quantitative assessment of morphine tolerance and physical dependence","volume":"167","author":"Way","year":"1969","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2013.01.022_bib61","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1152\/physrev.2001.81.1.299","article-title":"Cellular and synaptic adaptations mediating opioid dependence","volume":"81","author":"Williams","year":"2001","journal-title":"Physiol. Rev."},{"issue":"45","key":"10.1016\/j.neuropharm.2013.01.022_bib62","doi-asserted-by":"crossref","first-page":"13904","DOI":"10.1021\/bi001099p","article-title":"The conserved cysteine 7.38 residue is differentially accessible in the binding-site crevices of the mu, delta, and kappa opioid receptors","volume":"39","author":"Xu","year":"2000","journal-title":"Biochemistry"},{"issue":"21","key":"10.1016\/j.neuropharm.2013.01.022_bib63","doi-asserted-by":"crossref","first-page":"7207","DOI":"10.1128\/MCB.21.21.7207-7217.2001","article-title":"Raf kinase inhibitor protein interacts with NF-\u03baB-inducing kinase and TAK1 and inhibits NF-\u03baB activation","volume":"21","author":"Yeung","year":"2001","journal-title":"Mol. Cell. Biol."},{"issue":"12","key":"10.1016\/j.neuropharm.2013.01.022_bib64","doi-asserted-by":"crossref","first-page":"5302","DOI":"10.1073\/pnas.88.12.5302","article-title":"A\u00a0protein geranylgeranyltransferase from bovine brain: implications for protein prenylation specificity","volume":"88","author":"Yokoyama","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2013.01.022_bib65","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1146\/annurev.bi.65.070196.001325","article-title":"Protein prenylation: molecular mechanisms and functional consequences","volume":"65","author":"Zhang","year":"1996","journal-title":"Annu. Rev. Biochem."},{"issue":"2","key":"10.1016\/j.neuropharm.2013.01.022_bib66","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jss.2004.10.022","article-title":"Inhibition of geranylgeranyltransferase I decreases generation of vascular reactive oxygen species and increases vascular nitric oxide production","volume":"124","author":"Zuckerbraun","year":"2005","journal-title":"J.\u00a0Surg. Res."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390813000397?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390813000397?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,4,5]],"date-time":"2021-04-05T10:57:08Z","timestamp":1617620228000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390813000397"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":66,"alternative-id":["S0028390813000397"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2013.01.022","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]}}}